AN account of the mammotrophic potency of human urine was recently published in this journal (Hadfield and Young, 1956). The work now presented is a continuation of this enquiry and deals for the most part with the mammotrophic activity of the urine of post-menopausal women.
taneous injection twice daily for five days. The temperature of the urine should be allowed to rise to that of a warm room before injection. We have found these normal urines to be remarkably non-toxic.
The animals were killed and skinned on the sixth morning of the experiment, the skins fixed in Bouin's solution for 24 hours and then transferred to 50 per cent absolute alcohol. Each whole skin was then de-fatted by careful dehydration in absolute alcohol and immersion in several changes of xylol. This operation is carried out in a tissue processor. It very greatly enhances the intensity of staining and facilitates the rapid identification of the glands during dissection. The defatted skins are brought back to water and stained in Grenacher's alum carmine.
In each skin an average of five stained mammary glands were identified, dissected out at a magnification of 15 diameters, cleaned of excess fat and muscle, dehydrated and cleared. All the glands from each animal were mounted whole on the same slide without sectioning. It has been a common experience to find that of six mammary glands from one mouse stimulated by a potent urine, two or occasionally three fail to react vigorously and remain small and difficult to identify. It is essential that these small glands should be found and examined.
When the urinary potency is low the number of non-reacting glands is far larger and the final result will be erroneously high if their identification and examination be omitted.
The terminal clubs in each gland were counted. In glands undergoing differentiation and showing replacement of clubs by a cluster of terminal acini, each such acinar mass at a duct end was counted as a club. The total number of clubs in all glands was divided by the total number of glands examined, giving the average clubs per gland. This figure was divided by 1.14, i.e. the average number of clubs per normal gland in the male weanling of the strain we used. This final figure-the mammotrophic "potency "-was regarded as significant if it reached a value of 4 or more. The degree of" acinisation "was determined by enumerating all glands showing clear evidence of glandular differentiation at a magnification of 50 diameters, and expressing this figure as a percentage of all glands examined.
Urines in which the mammotrophic potency is high invariably produce a high percentage of acinised glands.
RESULTS
The detailed results of the investigation are shown in Table I . On this basis the results obtained from urines extending over all post-menopausal age groups (1 to 36 years) may be summarised as indicated in Table III . It is interesting to compare these figures with those obtained from pre-menopausal urines. In doing so the variations in mammotrophic potency during the menstrual cycle must be taken into account. During the first half of the cycle the potency is low; during the second half, between the 17th and 22nd days, it reaches a maximum which varies between 6 and 16.8. A comparable potency range from 6 to 14.5 was found in 25 of the 57 post-menopausal urines examined (i.e. 43.8 per cent). It would therefore appear that the urine of 43.8 per cent of normal post-menopausal women has a mammotrophic potency which fairly closely approximates to that of the normal pre-menopausal woman between the 17th and 22nd days of the cycle.
There is one substantial difference between the pre-and post-menopausal woman in respect of mammotrophic potency. Even during the first half of the cycle, pre-menopausal urine is nearly always potent although the value is low, and very few specimens have no potency. In contrast, potency was completely absent in 24.5 per cent of urines collected over the whole post-menopausal age period, i.e. from 1 to 36 years after cessation of the menses.
Suggestive information is provided by comparing the mammotrophic potency of urines from normal post-menopausal women in all age groups with the results m of cytological examination of vaginal smears and histological examination of the endometrium over the same period. In Table V These results immediately recall the well-established physiological castration phenomenon which occurs in a considerable proportion of post-menopausal women. Ovarian function fails, the blood oestrogen falls and a low blood oestrogen being the appropriate physiological stimulus for the production of gonadotrophin by the hypophysis, the output of this hormone rises and remains high as long as the oestrogen remains low. In Table V As our figures for the mammotrophic potency of the urine are almost identical with the predicted figures for pituitary gonadtrophin, it is reasonable to suppose that the mammotrophic potency of post-menopausal urine is, in part at least, due to the liberation of a mammotrophic pituitary hormone whose production in post-menopausal women is governed by the same reciprocal relationship with failure of ovarian function as that of gonadotrophin. This supposition obviously needs the confirmation which can only be provided by the simultaneous estimation of the vaginal response, the urinary output of a mammotrophic hormone or hormones and of gonadotrophin in each of a larger series of post-menopausal women than we have been able to examine. The agreement between the two sets of figures also suggests that our numerical criteria for deciding whether a specimen of urine should be regarded as possessing mammotrophic potency or not are reasonably accurate.
When urinary potencies were placed in five-year post-menopausal age groups their distribution from the 16th year onwards was found to be too irregular for satisfactory analysis. This is clearly due to the small number of specimens examined. Analysis of the three periods 0 to 5, 6 to 10 and 11 to 15 years was more satisfactory and showed a significant general tendency for the potency to fall with advancing years. This trend is emphasized if urines showing weak potency or giving an indeterminate result are excluded. Fig. 2 shows the fall in the percentage of urines having considerable potency and an associated rise in those in which potency was absent.
On the other hand, reference to Table I in which our results are shown in detail, will demonstrate that in all the older age groups up to the 29th post-menopausal year there are individuals whose urinary potency is at a high level and examples of these are shown in Table VI . 
ADDENDUM
It has been recently discovered that in some strains of albino mice the mammary glands of the weanling males do not react to injections of human urine or to prolactin. It is obvious, therefore, that before carrying out an estimation of the mammotrophic potency of human urine, a group of male weanlings of the strain of mice it is proposed to use should be tested for reactivity by injecting the urine of a normal pre-menopausal woman collected between the 18th and 23rd days of the menstrual cycle.
